| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Division of Endocrinology, The Childrens Hospital of Philadelphia, and Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
Address all correspondence and requests for reprints to: Charles A. Stanley, M.D., Division of Endocrinology, Childrens Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, Pennsylvania 19104-6205. E-mail: stanleyc{at}email.chop.edu
Abstract
Mutations of glutamate dehydrogenase cause the hyperinsulinism/hyperammonemia syndrome by desensitizing glutamate dehydrogenase to allosteric inhibition by GTP. Normal allosteric activation of glutamate dehydrogenase by leucine is thus uninhibited, leading us to propose that children with hyperinsulinism/hyperammonemia syndrome will have exaggerated acute insulin responses to leucine in the postabsorptive state. As hyperglycemia increases ß-cell GTP, we also postulated that high glucose concentrations would extinguish abnormal responsiveness to leucine in hyperinsulinism/hyperammonemia syndrome patients. After an overnight fast, seven hyperinsulinism/hyperammonemia syndrome patients (aged 9 months to 29 yr) had acute insulin responses to leucine performed using an iv bolus of L-leucine (15 mg/kg) administered over 1 min and plasma insulin measurements obtained at -10, -5, 0, 1, 3, and 5 min. The acute insulin response to leucine was defined as the mean increase in insulin from baseline at 1 and 3 min after an iv leucine bolus. The hyperinsulinism/hyperammonemia syndrome group had excessively increased insulin responses to leucine (mean ± SEM, 73 ± 21 µIU/ml) compared with the control children and adults (n = 17) who had no response to leucine (1.9 ± 2.7 µU/ml; P < 0.05). Four hyperinsulinism/hyperammonemia syndrome patients then had acute insulin responses to leucine repeated at hyperglycemia (blood glucose, 150180 mg/dl). High blood glucose suppressed their abnormal baseline acute insulin responses to leucine of 180, 98, 47, and 28 µU/ml to 73, 0, 6, and 19 µU/ml, respectively. This suppression suggests that protein-induced hypoglycemia in hyperinsulinism/hyperammonemia syndrome patients may be prevented by carbohydrate loading before protein consumption.
This article has been cited by other articles:
![]() |
A. A. Palladino, M. J. Bennett, and C. A. Stanley Hyperinsulinism in Infancy and Childhood: When an Insulin Level Is Not Always Enough Clin. Chem., February 1, 2008; 54(2): 256 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, A. Matter, A. Kelly, T. J. Petty, H. Najafi, C. MacMullen, Y. Daikhin, I. Nissim, A. Lazarow, J. Kwagh, et al. Effects of a GTP-insensitive Mutation of Glutamate Dehydrogenase on Insulin Secretion in Transgenic Mice J. Biol. Chem., June 2, 2006; 281(22): 15064 - 15072. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Henwood, A. Kelly, C. MacMullen, P. Bhatia, A. Ganguly, P. S. Thornton, and C. A. Stanley Genotype-Phenotype Correlations in Children with Congenital Hyperinsulinism Due to Recessive Mutations of the Adenosine Triphosphate-Sensitive Potassium Channel Genes J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 789 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Magge, S.-L. Shyng, C. MacMullen, L. Steinkrauss, A. Ganguly, L. E. L. Katz, and C. A. Stanley Familial Leucine-Sensitive Hypoglycemia of Infancy Due to a Dominant Mutation of the {beta}-Cell Sulfonylurea Receptor J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4450 - 4456. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, C. Buettger, J. Kwagh, A. Matter, Y. Daikhin, I. B. Nissim, H. W. Collins, M. Yudkoff, C. A. Stanley, and F. M. Matschinsky A Signaling Role of Glutamine in Insulin Secretion J. Biol. Chem., April 2, 2004; 279(14): 13393 - 13401. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Stanley, P. S. Thornton, A. Ganguly, C. MacMullen, P. Underwood, P. Bhatia, L. Steinkrauss, L. Wanner, R. Kaye, E. Ruchelli, et al. Preoperative Evaluation of Infants with Focal or Diffuse Congenital Hyperinsulinism by Intravenous Acute Insulin Response Tests and Selective Pancreatic Arterial Calcium Stimulation J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 288 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. DUNNE, K. E. COSGROVE, R. M. SHEPHERD, A. AYNSLEY-GREEN, and K. J. LINDLEY Hyperinsulinism in Infancy: From Basic Science to Clinical Disease Physiol Rev, January 1, 2004; 84(1): 239 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Thornton, C. MacMullen, A. Ganguly, E. Ruchelli, L. Steinkrauss, A. Crane, L. Aguilar-Bryan, and C. A. Stanley Clinical and Molecular Characterization of a Dominant Form of Congenital Hyperinsulinism Caused by a Mutation in the High-Affinity Sulfonylurea Receptor Diabetes, September 1, 2003; 52(9): 2403 - 2410. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kelly, C. Li, Z. Gao, C. A. Stanley, and F. M. Matschinsky Glutaminolysis and Insulin Secretion: From Bedside to Bench and Back Diabetes, December 1, 2002; 51(90003): S421 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Stanley Advances in Diagnosis and Treatment of Hyperinsulinism in Infants and Children J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4857 - 4859. [Full Text] [PDF] |
||||
![]() |
G. Bertrand, N. Ishiyama, M. Nenquin, M. A. Ravier, and J.-C. Henquin The Elevation of Glutamate Content and the Amplification of Insulin Secretion in Glucose-stimulated Pancreatic Islets Are Not Causally Related J. Biol. Chem., August 30, 2002; 277(36): 32883 - 32891. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |